Dragon’s Dogma 2 Commands Impressive Sales, Exceeding 2.5 Million Units

Dragon's Dogma 2
Dragon's Dogma 2

Global sales for Dragon’s Dogma 2 have reached over 2.5 million copies on PC, PlayStation 5, and Xbox Series X|S. The company behind the game, Capcom, shared this news in a press release on their investor page.

This achievement means that altogether, the Dragon’s Dogma series has sold more than 10 million copies across all platforms.

Dragon's Dogma 2
Dragon’s Dogma 2

The sequel, which fans have been waiting for, was released last month on March 22. It’s impressive that the game managed to sell so many copies in less than two weeks.

Capcom said in the press release, “Worldwide sales of Dragon’s Dogma 2 have surpassed 2.5 million units.” The Dragon’s Dogma series is known for its action-packed fantasy world where players can explore freely.

Ever since the first game came out in 2012, people have loved its unique features like the “pawn” companions who can act on their own.

Since the game came out, players on PC have been busy creating mods to enhance their experience.

These mods include things like changing stamina, adjusting the camera, and adding ray tracing for better graphics. Capcom also released an update last week, making improvements to things like DLSS quality and fixing bugs.

When we reviewed the game, we praised its exciting combat, beautiful graphics, and the vast world to explore. However, we also pointed out that it didn’t improve much on the weaknesses of the original game.

Still, Dragon’s Dogma 2 offers about 40 hours of fun gameplay with its exploration, combat, and visuals. Just don’t expect a deep storyline like some other fantasy games.

Since I adore investigating new topics, I've chosen journalism as my profession. I take great pleasure in following current events through the media. Working as an SEO editor allows me to combine my two favorite activities: reading and writing. I can usually read a book when I'm not glued to my screen working on a computer or watching the most recent news.